Flu News Friday: The Latest in Influenza Vaccines
2 min readNov 20, 2020
November 20, 2020
1. The Viruses Inside You
David Pride, Scientific American / December 2020 Issue
2. Preparing for the Next Pandemic
The M, Stephanie Sutton / November 19, 2020
3. Emergex Vaccines Raises US $11 million to Advance Pipeline of Synthetic T-Cell Vaccines for Infectious Diseases
Globe Newswire / November 18, 2020
4. Seasonal Influenza: The Challenges of Selecting a Vaccine Strain
Amanda Perofsky & Martha Nelson, The Wire / November 16, 2020
5. The long game: the race for a vaccine against all coronaviruses
Natalie Grover, The Guardian / November 13, 2020
6. Pfizer’s announcement shows the promise of gene-based vaccines
Nicole Wetsman, The Verge / November 12, 2020
7. WHO Recommendations for Monitoring COVID-19 and the Flu
Rachel Lutz, Contagion Live / November 11, 2020
8. Whole-Genome Synthesis Will Transform Cell Engineering: A big advance in synthetic biology
Andrew Hessel & Sang Yup Lee, Scientific American / November 10, 2020
9. Development and Assessment of a Pooled Serum as Candidate Standard to Measure Influenza A Virus Group 1 Hemagglutinin Stalk-Reactive Antibodies
Carreño et al., Vaccines / November 9, 2020
10. Synthetic biology gets a second wind
Chris Edwards, Engineering & Technology / November 5, 2020
11. Generation and Characterization of Universal Live-Attenuated Influenza Vaccine Candidates Containing Multiple M2e Epitopes
Kotomina et al., Vaccines / November 3, 2020
Visit Influenzer.org to learn more about our journey to accelerate the development of a universal influenza vaccine. @TheInfluenzers
